,

C. Aguilar and E. Westman, Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment". en, Psychiatry Research: Neuroimaging 212, vol.2, pp.89-98, 2013.

J. Arbizu, Automated analysis of FDG PET as a tool for singlesubject probabilistic prediction and detection of Alzheimer's disease dementia, European Journal of Nuclear Medicine and Molecular Imaging, vol.40, pp.1394-1405, 2013.

J. Arco, Short-term prediction of MCI to AD conversion based on longitudinal MRI analysis and neuropsychological tests, Smart Innovation, Systems and Technologies 45, pp.385-394, 2016.

B. A. Ardekani, Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment". en, Journal of Alzheimer's Disease, vol.55, pp.269-281, 2017.

A. Ayub, A novel approach for the prediction of conversion from mild cognitive impairment to Alzheimer's disease using MRI images, Advances in Electrical and Computer Engineering, vol.17, pp.113-122, 2017.

J. Beer, Does a cognitive stress test predict progression from mild cognitive impairment to dementia equally well in clinical versus population-based settings?, In: International Psychogeriatrics, vol.30, pp.1435-1445, 2018.

I. Beheshti and N. Maikusa, Classification of Alzheimer's disease and prediction of mild cognitive impairment conversion using histogram-based analysis of patient-specific anatomical brain connectivity networks, Journal of Alzheimer's Disease, vol.60, issue.1, pp.295-304, 2017.

I. Beheshti, H. Demirel, and H. Matsuda, Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm". en, Computers in Biology and Medicine, vol.83, pp.109-119, 2017.

S. Belleville, Predicting decline in mild cognitive impairment: A prospective cognitive study, pp.643-652, 2014.

B. Borroni, Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD, Neurobiology of Aging, vol.27, pp.24-31, 2006.

L. Buratti, Markers for the Risk of Progression from Mild Cognitive Impairment to Alzheimer's Disease, Journal of Alzheimer's Disease, vol.45, pp.883-890, 2015.

M. Buscema, model allows the prediction of conversion to alzheimer disease in patients with mild cognitive impairment with high degree of accuracy, Current Alzheimer Research, issue.2, pp.173-187, 2010.

J. Cabranes, Relevance of functional neuroimaging in the progression of mild cognitive impairment, Neurological Research, vol.26, pp.496-501, 2004.

B. Callahan, Predicting Alzheimer's disease development: A comparison of cognitive criteria and associated neuroimaging biomarkers, Alzheimer's Research and Therapy, 2015.

S. Caminiti, FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort, Neu-roImage: Clinical 18, pp.167-177, 2018.

R. Chen, Prediction of conversion from mild cognitive impairment to Alzheimer disease based on Bayesian data mining with ensemble learning, Neuroradiology Journal 25, vol.1, pp.5-16, 2012.

X. Chen, Potential clinical value of multiparametric pet in the prediction of Alzheimer's disease progression, PLoS ONE 11.5, 2016.

B. Cheng, M. Liu, and H. Suk, Multimodal manifold-regularized transfer learning for MCI conversion prediction, Brain Imaging and Behavior 9, vol.4, pp.913-926, 2015.

B. Cheng, M. Liu, and D. Zhang, Domain Transfer Learning for MCI Conversion Prediction, IEEE Transactions on Biomedical Engineering, vol.62, pp.1805-1817, 2015.

A. Chincarini, Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease, pp.469-480, 2011.

Y. Cho, Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data, pp.2217-2230, 2012.

H. Choi and K. Jin, Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging, Behavioural Brain Research, vol.344, pp.103-109, 2018.

I. Choo, Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients, Journal of Alzheimer's Disease, vol.33, pp.929-939, 2013.

F. Çitak-er, A novel convolutional neural network model based on voxel-based morphometry of imaging data in predicting the prognosis of patients with mild cognitive impairment, Journal of Neurological Sciences, vol.34, issue.1, pp.52-69, 2017.

D. Clark, Residual vectors for Alzheimer disease diagnosis and prognostication, Brain and Behavior, vol.1, issue.2, pp.142-152, 2011.

D. Clark and P. Kapur, Latent Information in Fluency Lists Predicts Functional Decline in Persons at Risk for Alzheimer Disease, Cortex; a journal devoted to the study of the nervous system and behavior 55, pp.202-218, 2014.

D. Clark and P. Mclaughlin, Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment, pp.113-122, 2016.

L. Collij, Application of machine learning to arterial spin labeling in mild cognitive impairment and Alzheimer disease, pp.865-875, 2016.

A. Convit, Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease, Neurobiology of Aging, vol.21, pp.19-26, 2000.

S. Costafreda, Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment, pp.212-219, 2011.

Y. Cui, Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors, PLOS ONE 6.7, e21896, 2011.

R. Cuingnet, Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of ten methods using the ADNI database, pp.766-781, 2011.

C. Davatzikos, Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification, Neurobiology of Aging, vol.32, 2011.

D. Devanand and X. Liu, Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease". In: Biological Psychiatry 64, vol.10, pp.871-879, 2008.

D. Devanand and G. Pradhaban, Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease, Neurology 68.11, pp.828-836, 2007.

D. Devanand and R. Van-heertum, 99mTc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease, American Journal of Geriatric Psychiatry, vol.18, pp.959-972, 2010.

E. Dierckx, Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment, International Journal of Geriatric Psychiatry, vol.24, pp.1094-1100, 2009.

O. Doyle, Predicting progression of Alzheimer's disease using ordinal regression, PLoS ONE 9, vol.8, 2014.

A. Drzezga, Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET, Journal of Nuclear Medicine, vol.46, pp.1625-1632, 2005.

S. Duchesne, Amnestic MCI future clinical status prediction using baseline MRI features, Neurobiology of Aging, vol.31, pp.1606-1617, 2010.

J. Dukart, F. Sambataro, and A. Bertolino, Accurate prediction of conversion to Alzheimer's disease using imaging, genetic, and neuropsychological biomarkers, 2015.

, Journal of Alzheimer's Disease, vol.49, pp.1143-1159

S. Eskildsen, P. Coupé, and V. Fonov, Structural imaging biomarkers of Alzheimer's disease: Predicting disease progression, Neurobiology of Aging 36.S1, S23-S31, 2015.

S. Eskildsen, P. Coupé, and D. García-lorenzo, Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning, NeuroImage, vol.65, pp.511-521, 2013.

M. Ewers and K. Buerger, Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI, Neurology 69, vol.24, pp.2205-2212, 2007.

M. Ewers and C. Walsh, Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance, Neurobiology of Aging, vol.33, pp.1203-1214, 2012.

F. Falahati, The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects, Brain Topography, vol.29, pp.296-307, 2016.

N. Fayed, Magnetic resonance spectroscopy and brain volumetry in mild cognitive impairment. A prospective study, Magnetic Resonance Imaging, vol.38, pp.27-32, 2017.

F. Ferreira, Improving prognostic prediction from mild cognitive impairment to Alzheimer's disease using genetic algorithms, Advances in Intelligent Systems and Computing 616, pp.180-188, 2017.

A. Fleisher, Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment, Neurology 70.3, pp.191-199, 2008.

K. Fritzsche, Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment, International Journal of Computer Assisted Radiology and Surgery, vol.5, pp.623-632, 2010.

L. Frölich, Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia, vol.1, 2017.

D. Gallagher, Detecting prodromal Alzheimer's disease in mild cognitive impairment: Utility of the CAMCOG and other neuropsychological predictors, International Journal of Geriatric Psychiatry, vol.25, pp.1280-1287, 2010.

S. García-herranz, M. Díaz-mardomingo, and H. Peraita, Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment, Journal of Neuropsychology, vol.10, pp.239-255, 2016.

C. Gaser, BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease, PLoS ONE 8.6, 2013.

G. Gavidia-bovadilla, Early prediction of Alzheimer's disease using null longitudinal model-based classifiers, PLoS ONE 12.1, 2017.

D. Geslani, Mild cognitive impairment: An operational definition and its conversion rate to Alzheimer's disease, Dementia and Geriatric Cognitive Disorders, vol.19, pp.383-389, 2005.

H. Griffith, Amnestic mild cognitive impairment: Diagnostic outcomes and clinical prediction over a two-year time period, Journal of the International Neuropsychological Society, vol.12, pp.166-175, 2006.

S. Guo, Conversion discriminative analysis on mild cognitive impairment using multiple cortical features from MR images, Frontiers in Aging Neuroscience 9, 2017.

A. Hall, Predicting progression from cognitive impairment to alzheimer's disease with the disease state index, Current Alzheimer Research, vol.12, issue.1, pp.69-79, 2015.

C. Hinrichs, Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population, NeuroImage 55, vol.2, pp.574-589, 2011.

S. Hojjati, A. Ebrahimzadeh, A. Khazaee, and A. Babajani-feremi, Predicting conversion from MCI to AD using resting-state fMRI, graph theoretical approach and SVM, Journal of Neuroscience Methods, vol.282, pp.69-80, 2017.

S. Hojjati, A. Ebrahimzadeh, A. Khazaee, A. Babajani-feremi, and D. N. , Predicting conversion from MCI to AD by integrating rs-fMRI and structural MRI, Computers in Biology and Medicine, vol.102, pp.30-39, 2018.

C. Huang, Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment, BMC Neurology, vol.2, 2002.

M. Huang, Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease, Scientific Reports, vol.7, p.39880, 2017.

P. Johnson, Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease, BMC Bioinformatics, vol.15, 2014.

J. Ding and Q. Huang, Prediction of MCI to AD conversion using Laplace Eigenmaps learned from FDG and MRI images of AD patients and healthy controls". en, 2017 2nd International Conference on Image, Vision and Computing (ICIVC), pp.660-664, 2017.

K. Kauppi, Combining polygenic hazard score with volumetric MRI and cognitive measures improves prediction of progression from mild cognitive impairment to Alzheimer's disease, Frontiers in Neuroscience 12.APR, 2018.

V. Kebets, Predicting Pure Amnestic Mild Cognitive Impairment Conversion to Alzheimer's Disease Using Joint Modeling of Imaging and Clinical Data, Proceedings -2015 International Workshop on Pattern Recognition in NeuroImaging, pp.85-88, 2015.

W. Khan and C. Aguilar, A subset of cerebrospinal fluid proteins from a multi-analyte panel associated with brain atrophy, disease classification and prediction in Alzheimer's disease, PLoS ONE 10.8, 2015.

W. Khan and E. Westman, Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts, Brain Topography, vol.28, pp.746-759, 2015.

J. W. Kim, Clinical Dementia Rating Orientation Score as an Excellent Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment". en, Psychiatry Investigation, vol.14, p.420, 2017.

S. Klöppel, Applying automated MR-based diagnostic methods to the memory clinic: A prospective study, Journal of Alzheimer's Disease, vol.47, pp.939-954, 2015.

A. Koppara, The latent dementia phenotype ? is associated with cerebrospinal fluid biomarkers of Alzheimer's disease and predicts conversion to dementia in subjects with mild cognitive impairment, Journal of Alzheimer's Disease, vol.49, pp.547-560, 2015.

I. O. Korolev, Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification". en, PLOS ONE, vol.11, issue.2, p.138866, 2016.

M. Kruczyk, Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment, Journal of Neural Transmission, vol.119, pp.821-831, 2012.

B. Lehallier, Combined plasma and cerebrospinal fluid signature for the prediction of midterm progression from mild cognitive impairment to Alzheimer disease, JAMA Neurology, vol.73, pp.203-212, 2016.

B. Lei and S. Chen, Discriminative learning for Alzheimer's disease diagnosis via canonical correlation analysis and multimodal fusion, Frontiers in Aging Neuroscience 8.MAY, 2016.

B. Lei and P. Yang, Relational-Regularized Discriminative Sparse Learning for Alzheimer's Disease Diagnosis". en, IEEE Transactions on Cybernetics, vol.47, pp.1102-1113, 2017.

H. Li, Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion, PLoS ONE 9, vol.1, 2014.

Y. Li and J. Jiang, Radiomics features as predictors to distinguish fast and slow progression of Mild Cognitive Impairment to Alzheimer's disease, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp.127-130, 2018.

Y. Li and Z. Yao, Indirect relation based individual metabolic network for identification of mild cognitive impairment, Journal of Neuroscience Methods, vol.309, pp.188-198, 2018.

W. Lin, Convolutional neural networks-based MRI image analysis for the Alzheimer's disease prediction from mild cognitive impairment, Frontiers in Neuroscience 12.NOV, 2018.

H. Liu, A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer's disease, Scientific Reports, vol.6, 2016.

X. Liu, Locally linear embedding (LLE) for MRI based Alzheimer's disease classification, NeuroImage, vol.83, pp.148-157, 2013.

X. Long, Prediction and classification of Alzheimer disease based on quantification of MRI deformation, PLoS ONE 12.3, 2017.

J. Lonie, Predicting outcome in mild cognitive impairment: 4-Year follow-up study, British Journal of Psychiatry, vol.197, pp.135-140, 2010.

M. López, Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study, Journal of Alzheimer's Disease, vol.52, pp.133-143, 2016.

F. Mangialasche, Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of ?-/?-tocotrienols and ?-tocopherol, Journal of Internal Medicine, vol.273, pp.602-621, 2013.

A. Marcos, Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease, American Journal of Alzheimer, pp.189-196, 2006.

C. Marra, Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS), Journal of Alzheimer's Disease, vol.50, pp.61-70, 2015.

F. Martinez-murcia, Assessing mild cognitive impairment progression using a spherical brain mapping of magnetic resonance imaging, Journal of Alzheimer's Disease, vol.65, pp.713-729, 2018.

A. Martínez-torteya, MRI signal and texture features for the prediction of MCI to Alzheimer's disease progression, Progress in Biomedical Optics and Imaging -Proceedings of SPIE, vol.9035, p.903526, 2014.

S. Mathotaarachchi, Identifying incipient dementia individuals using machine learning and amyloid imaging, Neurobiology of Aging, 2017.

S. Mazzeo, Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia, Journal of Alzheimer's Disease, vol.54, pp.1495-1508, 2016.

S. Minhas, A. Khanum, F. Riaz, and A. Alvi, Early alzheimer's disease prediction in machine learning setup: Empirical analysis with missing value computation, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 9375 LNCS, pp.424-432, 2015.

S. Minhas, A. Khanum, F. Riaz, and A. Alvi, A Nonparametric Approach for Mild Cognitive Impairment to AD Conversion Prediction: Results on Longitudinal Data, IEEE Journal of Biomedical and Health Informatics, vol.21, pp.1403-1410, 2017.

S. Minhas, A. Khanum, F. Riaz, and S. Khan, Predicting progression from mild cognitive impairment to Alzheimer's disease using autoregressive modelling of longitudinal and multimodal biomarkers, 2017 IEEE EMBS International Conference on Biomedical and Health Informatics, vol.22, pp.818-825, 2017.

C. Misra, Y. Fan, and C. Davatzikos, Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI". eng, NeuroImage, vol.44, pp.1415-1422, 2009.

J. Mitchell, Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm, Journal of Neurology, vol.256, pp.1500-1509, 2009.

P. J. Modrego, N. Fayed, and M. Sarasa, Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study". en, BMJ Open 1, vol.1, pp.7-000007, 2011.

P. Modrego, N. Fayed, and M. Pina, Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy, American Journal of Psychiatry, vol.162, pp.667-675, 2005.

E. Moradi, Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects, NeuroImage 104.Supplement C, pp.398-412, 2015.

D. Moretti, MCI patients' EEGs show group differences between those who progress and those who do not progress to AD, Neurobiology of Aging, vol.32, pp.563-571, 2011.

A. Mubeen, A six-month longitudinal evaluation significantly improves accuracy of predicting incipient Alzheimer's disease in mild cognitive impairment, Journal of Neuroradiology, vol.44, pp.381-387, 2017.

M. Nesteruk, Combined use of biochemical and volumetric biomarkers to assess the risk of conversion of mild cognitive impairment to Alzheimer's disease, Folia Neuropathologica, vol.54, pp.369-374, 2016.

K. Nho, Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance Imaging, Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, pp.542-546, 2010.

K. Ning, Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework, Neurobiology of Aging, vol.68, pp.151-158, 2018.

K. Ota, Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers, Journal of Neuroscience Methods, vol.256, pp.1385-1401, 2015.

V. Papaliagkas, Usefulness of event-related potentials in the assessment of mild cognitive impairment, BMC Neuroscience, vol.9, 2008.

H. Park, Dimensionality reduced cortical features and their use in predicting longitudinal changes in Alzheimer's disease, Neuroscience Letters, vol.550, pp.17-22, 2013.

L. Parnetti, Performance of A?1-40, A?1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment, Journal of Alzheimer's Disease, vol.29, pp.229-238, 2012.

F. Peters, S. Villeneuve, and S. Belleville, Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors, Journal of Alzheimer's Disease, vol.38, pp.307-318, 2014.

C. Plant, Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease, pp.162-174, 2010.

M. Plocharski and L. R. Østergaard, Prediction of Alzheimer's Disease in Mild Cognitive Impairment Using Sulcal Morphology and Cortical Thickness". en, World Congress on Medical Physics and Biomedical Engineering, pp.69-74, 2018.

S. Poil, Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage, Frontiers in Aging Neuroscience 5.OCT, 2013.

K. Popuri, Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging, NeuroImage: Clinical, vol.18, pp.802-813, 2018.

D. Quaranta, Are raw scores on memory tests better than age-and education-adjusted scores for predicting progression from amnesic mild cognitive impairment to Alzheimer disease?, In: Current Alzheimer Research, vol.13, pp.1414-1420, 2016.

P. Raamana, Thickness network features for prognostic applications in dementia, Neurobiology of Aging 36.S1, S91-S102, 2015.

L. Rabin, Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease, Aging, Neuropsychology, and Cognition, vol.16, issue.3, pp.357-376, 2009.

A. Retico, Predictive Models Based on Support Vector Machines: Whole-Brain versus Regional Analysis of Structural MRI in the Alzheimer's Disease, Journal of Neuroimaging, vol.25, pp.552-563, 2015.

H. Rhodius-meester, Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers, Journal of Alzheimer's Disease, vol.50, pp.261-270, 2015.

E. Richard, MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: A diagnostic accuracy study, BMJ Open 3, vol.6, 2013.

K. Ritter, Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers". en, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1, pp.206-215, 2015.

P. Rocha-de and M. , Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease, PLoS ONE 6.3, 2011.

J. Rodriguez, Short-term MCI-to-AD prediction using MRI, neuropsychological scores and ensemble tree learning techniques, 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference, pp.1-3, 2015.

M. Sabuncu, A Bayesian algorithm for image-based time-to-event prediction, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 8184 LNCS, pp.74-81, 2013.

G. Sanroma, Early prediction of alzheimer's disease with non-local patch-based longitudinal descriptors, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 10530 LNCS, pp.74-81, 2017.

J. Shaffer, Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers, Radiology 266, vol.2, pp.583-591, 2013.

T. Shen, Decision Supporting Model for One-year Conversion Probability from MCI to AD using CNN and SVM, Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol.2018, pp.738-741, 2018.

Y. Shmulev, M. Belyaev, and A. D. The, Predicting conversion of mild cognitive impairments to alzheimer's disease and exploring impact of neuroimaging, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 11044 LNCS, pp.83-91, 2018.

B. Si, I. Yakushev, and J. Li, A sequential tree-based classifier for personalized biomarker testing of Alzheimer's disease risk, IISE Transactions on Healthcare Systems Engineering, pp.248-260, 2017.

J. Snaedal, The use of EEG in Alzheimer's disease, with and without scopolamine -A pilot study, Clinical Neurophysiology, vol.121, pp.836-841, 2010.

B. Sohn, Comparison of regional gray matter atrophy, white matter alteration, and glucose metabolism as a predictor of the conversion to alzheimer's disease in mild cognitive impairment, Journal of Korean Medical Science, vol.30, pp.779-787, 2015.

H. Suk, S. Lee, and D. Shen, Deep ensemble learning of sparse regression models for brain disease diagnosis, Medical Image Analysis, vol.37, pp.101-113, 2017.

M. Summers and N. Saunders, Neuropsychological measures predict decline to alzheimer's dementia from mild cognitive impairment, Neuropsychology 26, vol.4, pp.498-508, 2012.

T. Tanpitukpongse, Predictive utility of marketed volumetric software tools in subjects at risk for Alzheimer disease: Do regions outside the hippocampus matter?, In: American Journal of Neuroradiology, vol.38, pp.546-552, 2017.

S. Teipel, The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment -Beyond classical regression, NeuroImage: Clinical, vol.8, pp.583-593, 2015.

K. Thung, Conversion and time-to-conversion predictions of mild cognitive impairment using low-rank affinity pursuit denoising and matrix completion, Medical Image Analysis, vol.45, pp.68-82, 2018.

M. Tondelli, Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: A clinical cohort study, Clinical Chemistry and Laboratory Medicine, vol.53, issue.3, pp.453-460, 2015.

T. Tong and Q. Gao, Extraction of features from patch based graphs for the prediction of disease progression in AD, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 9226, pp.500-509, 2015.

T. Tong and Q. Gao, A novel grading biomarker for the prediction of conversion from mild cognitive impairment to Alzheimer's disease, IEEE Transactions on Biomedical Engineering, vol.64, pp.155-165, 2017.

P. Trzepacz, Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to alzheimer's dementia, Neurobiology of Aging, vol.35, pp.143-151, 2014.

N. Valencia and J. Lehrner, Screening for dementia with the Vienna Visuo-Constructional Test 3.0 screening (VVT 3.0 screening), pp.196-203, 2018.

D. Vecchio, Sustainable method for Alzheimer dementia prediction in mild cognitive impairment: Electroencephalographic connectivity and graph theory combined with apolipoprotein E, Annals of Neurology, vol.84, pp.302-314, 2018.

P. Visser, Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment, Journal of Neurology, vol.246, pp.477-485, 1999.

G. Vivar, Multi-modal Disease Classification in Incomplete Datasets Using Geometric Matrix Completion, 2018.

P. Wang, Multimodal classification of mild cognitive impairment based on partial least squares, Journal of Alzheimer's Disease, vol.54, issue.1, pp.359-371, 2016.

R. Wei, Prediction of conversion from mild cognitive impairment to Alzheimer's disease using MRI and structural network features, Frontiers in Aging Neuroscience 8.APR, 2016.

E. Westman and C. Aguilar, Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment, Brain Topography 26.1, pp.9-23, 2013.

E. Westman and L. Cavallin, Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease, PLoS ONE 6.7, 2011.

E. Westman, J. Muehlboeck, and A. Simmons, Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion, pp.229-238, 2012.

E. Westman, A. Simmons, and J. Muehlboeck, AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America, NeuroImage 58.3, pp.818-828, 2011.

E. Westman, A. Simmons, and Y. Zhang, Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls, NeuroImage 54, vol.2, pp.1178-1187, 2011.

L. Xu, Prediction of progressive mild cognitive impairment by multimodal neuroimaging biomarkers, Journal of Alzheimer's Disease, vol.51, pp.1045-1056, 2016.

X. Yang, M. Tan, and A. Qiu, CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade, PLoS ONE 7.12, 2012.

D. Ye, K. Pohl, and C. Davatzikos, Semi-supervised pattern classification: Application to structural MRI of Alzheimer's disease, Proceedings -International Workshop on Pattern Recognition in NeuroImaging, PRNI 2011, pp.1-4, 2011.

J. Ye, Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data, BMC Neurology, vol.12, 2012.

A. Young, A data-driven model of biomarker changes in sporadic Alzheimer's disease, Brain 137.9, pp.2564-2577, 2014.

J. Young, An oblique approach to prediction of conversion to alzheimer's disease with multikernel gaussian processes, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 9444 LNAI, pp.122-128, 2016.

P. Yu, Enriching amnestic mild cognitive impairment populations for clinical trials: Optimal combination of biomarkers to predict conversion to dementia, Journal of Alzheimer's Disease, vol.32, pp.373-385, 2012.

D. Zhang and D. Shen, Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease, NeuroImage 59, vol.2, pp.895-907, 2012.

D. Zhang, D. Shen, and A. D. Initiative, Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers, PLOS ONE 7.3, e33182, 2012.

H. Zhang, Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease, vol.1, 2018.

Y. Zhao, Predicting MCI progression with individual metabolic network based on longitudinal FDG-PET, Proceedings -2017 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2017, pp.1894-1899, 2017.

W. Zheng, Identification of Alzheimer's Disease and Mild Cognitive Impairment Using Networks Constructed Based on Multiple Morphological Brain Features". en, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 3.10, pp.887-897, 2018.

X. Zhu, H. Suk, and D. Shen, A novel matrix-similarity based loss function for joint regression and classification in AD diagnosis, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 8675 LNCS.PART, vol.100, pp.401-408, 2014.

X. Zhu, H. Suk, and L. Wang, A novel relational regularization feature selection method for joint regression and classification in AD diagnosis, Medical Image Analysis, vol.38, pp.205-214, 2017.

L. M. Aksman, « Longitudinal neuroimaging features for discriminating early neurodegeneration, 2017.

H. Amieva and H. Jacqmin-gadda, « The 9 year cognitive decline before dementia of the Alzheimer type : a prospective population-based study ». en. In : Brain 128, vol.5, pp.1093-1101, 2005.

H. Amieva and H. Mokri, « Compensatory mechanisms in higher-educated subjects with Alzheimer's disease : a study of 20 years of cognitive decline ». en, Brain, vol.137, pp.1167-1175, 2014.

M. Ansart, S. Epelbaum, G. Gagliardi, O. Colliot, D. Dormont et al., « Reduction of recruitment costs in preclinical AD trials : validation of automatic pre-screening algorithm for brain amyloidosis ». en, Statistical Methods in Medical Research, p.096228021882303, 2019.

M. Ansart, S. Epelbaum, G. Gagliardi, O. Colliot, D. Dormont et al., « Prediction of Amyloidosis from Neuropsychological and MRI Data for Cost Effective Inclusion of Pre-symptomatic Subjects in, Deep Learning in Medical Image Analysis and Multimodal Learning for Clinical Decision Support. T. 10553, pp.357-364, 2017.

K. Antila, « The PredictAD project : development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease, Interface Focus, 2013.

L. G. Apostolova, « Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures, Neurology 84, vol.7, pp.729-737, 2015.

M. R. Arbabshirani, « Single subject prediction of brain disorders in neuroimaging : Promises and pitfalls, NeuroImage. Individual Subject Prediction, vol.145, pp.137-165, 2017.

B. A. Ardekani, « Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment ». en. In : Journal of Alzheimer's Disease 55, vol.1, pp.269-281, 2017.

A. Atramont, « Health status and drug use 1 year before and 1 year after skilled nursing home admission during the first quarter of 2013 in France : a study based on the French National Health Insurance Information System, European Journal of Clinical Pharmacology, vol.74, pp.109-118, 2018.

D. E. Barnes and K. Yaffe, « The Projected Impact of Risk Factor Reduction on Alzheimer's Disease Prevalence, Lancet neurology 10, vol.9, pp.819-828, 2011.

R. J. Bateman, « Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease ». en, New England Journal of Medicine, vol.367, pp.795-804, 2012.

T. G. Beach, « Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer's Disease Centers, Journal of Neuropathology and Experimental Neurology, vol.71, pp.266-273, 2005.

R. E. Becker and N. H. Greig, « A New Regulatory Road-Map for Alzheimer's Disease Drug Development, Current Alzheimer research, vol.11, pp.215-220, 2014.

I. Beheshti, H. Demirel, and H. Matsuda, « Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm, Computers in Biology and Medicine, vol.83, pp.109-119, 2017.

F. A. Biétry, « Benzodiazepine Use and Risk of Developing Alzheimer's Disease : A Case-Control Study Based on Swiss Claims Data ». en, CNS Drugs, vol.31, pp.245-251, 2017.

S. Billioti-de-gage, « Benzodiazepine use and risk of Alzheimer's disease : case-control study ». eng, BMJ (Clinical research, vol.349, 2014.

J. S. Birks and J. Evans, « Rivastigmine for Alzheimer's disease ». eng, The Cochrane Database of Systematic Reviews, vol.4, p.1191, 2015.

L. Breiman, « Random forests, Machine learning 45, vol.1, pp.5-32, 2001.

G. Cheng, « Diabetes as a risk factor for dementia and mild cognitive impairment : a meta-analysis of longitudinal studies ». eng, Internal Medicine Journal, vol.42, pp.484-491, 2012.

G. Chételat, « Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease, NeuroImage : Clinical, vol.2, pp.356-365, 2013.

G. D. Chiara, « Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice ». en, PLOS Pathogens, vol.15, 2019.

A. Chincarini, « Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease, NeuroImage 58, vol.2, pp.469-480, 2011.

H. Choi and K. Jin, « Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging, Behavioural Brain Research, vol.344, pp.103-109, 2018.

M. Chupin, « Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints : method and validation ». eng, Neu-roImage, vol.46, pp.749-761, 2009.

C. M. Clark, « Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-? plaques : a prospective cohort study, The Lancet Neurology 11, vol.8, pp.70142-70146, 2012.

Y. Cui, « Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors, PLOS ONE 6, vol.7, 2011.

R. Cuingnet, « Automatic classification of patients with Alzheimer's disease from structural MRI : A comparison of ten methods using the ADNI database ». en, NeuroImage 56, vol.2, pp.766-781, 2011.

C. Davatzikos, « Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification, Neurobiology of Aging, vol.32, 2011.

Y. Ding, « A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain, Radiology 290, vol.2, pp.456-464, 2018.

P. Domingos, « A few useful things to know about machine learning ». en, Communications of the ACM 55, vol.10, p.78, 2012.

K. Donegan, Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015 : a longitudinal retrospective cohort study, vol.2, pp.30031-30033, 2017.

R. S. Doody, « Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease, New England Journal of Medicine, vol.370, pp.311-321, 2014.

O. Doyle, « Predicting progression of Alzheimer's disease using ordinal regression, PLoS ONE 9, 2014.

B. Dubois, H. H. Feldman, C. Jacova, and S. T. Dekosky, « Research criteria for the diagnosis of Alzheimer's disease : revising the NINCDS-ADRDA criteria, The Lancet. Neurology, vol.6, pp.70178-70181, 2007.

B. Dubois, H. H. Feldman, C. Jacova, and H. Hampel, « Advancing research diagnostic criteria for Alzheimer's disease : the IWG-2 criteria, The Lancet Neurology, vol.13, pp.614-629, 2014.

B. Dubois and H. Hampel, « Preclinical Alzheimer's disease : Definition, natural history, and diagnostic criteria, Alzheimer's & Dementia, vol.12, pp.292-323, 2016.

J. Dukart, F. Sambataro, and A. Bertolino, « Accurate prediction of conversion to Alzheimer's disease using imaging, genetic, and neuropsychological biomarkers, Journal of Alzheimer's Disease, vol.49, pp.1143-1159, 2015.

B. Efron, « Estimating the Error Rate of a Prediction Rule : Improvement on Cross-Validation, Journal of the American Statistical Association, vol.78, pp.316-331, 1983.

S. Epelbaum and R. Genthon, « Preclinical Alzheimer's disease : A systematic review of the cohorts underlying the concept, Alzheimer's & Dementia : The Journal of the Alzheimer's Association 13, vol.4, pp.454-467, 2017.

S. Epelbaum and C. Paquet, « How many patients are eligible for diseasemodifying treatment in Alzheimer's disease ? A French national observational study over 5 years ». en, BMJ Open 9, vol.6, 2019.

V. Escott-price, « Common polygenic variation enhances risk prediction for Alzheimer's disease, Brain 138, vol.12, pp.3673-3684, 2015.

S. Eskildsen, « Structural imaging biomarkers of Alzheimer's disease : Predicting disease progression, Neurobiology of Aging, vol.36, 2015.

F. Falahati, E. Westman, and A. Simmons, « Multivariate Data Analysis and Machine Learning in Alzheimer's Disease with a Focus on Structural Magnetic Resonance Imaging ». en, Journal of Alzheimer's Disease, vol.41, pp.685-708, 2014.

A. Fleisher, « Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment, Neurology 70, vol.3, pp.191-199, 2008.

J. C. Foster, J. M. Taylor, and S. J. Ruberg, « Subgroup identification from randomized clinical trial data ». en, Statistics in Medicine, vol.30, pp.2867-2880, 2011.

K. Franke, « Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods : Exploring the influence of various parameters, NeuroImage, vol.50, pp.883-892, 2010.

J. Friedman, T. Hastie, and R. Tibshirani, « Additive logistic regression : a statistical view of boosting, The annals of statistics 28, vol.2, pp.337-407, 2000.

J. H. Friedman, « Greedy Function Approximation : A Gradient Boosting Machine, The Annals of Statistics, vol.29, pp.1189-1232, 2001.

J. Friedman, T. Hastie, and R. Tibshirani, « Regularization paths for generalized linear models via coordinate descent, Journal of statistical software, vol.33, p.1, 2010.

G. Gavidia-bovadilla, « Early prediction of Alzheimer's disease using null longitudinal model-based classifiers, PLoS ONE, 2017.

M. Gómez-sancho, J. Tohka, and V. Gómez-verdejo, « Comparison of feature representations in MRI-based MCI-to-AD conversion prediction ». en, Magnetic Resonance Imaging, vol.50, pp.84-95, 2018.

K. R. Gray, « Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease, NeuroImage 60.1, pp.221-229, 2012.

S. L. Gray, « Benzodiazepine use and risk of incident dementia or cognitive decline : prospective population based study ». eng, BMJ (Clinical research, vol.352, p.90, 2016.

A. Hall, « Predicting progression from cognitive impairment to alzheimer's disease with the disease state index, Current Alzheimer Research, vol.12, pp.69-79, 2015.

S. Haller, K. O. Lovblad, P. Giannakopoulos-;-de, and J. W. Ashford, « Principles of Classification Analyses in Mild Cognitive Impairment (MCI) and Alzheimer Disease ». en. In : Journal of Alzheimer's Disease 26.s3. Sous la dir, pp.389-394, 2011.

L. Hamelin, « Early and protective microglial activation in Alzheimer's disease : a prospective study using 18F-DPA-714 PET imaging ». eng, Brain : A Journal of Neurology, vol.139, pp.1252-1264, 2016.

D. J. Hand and R. J. Till, « A simple generalisation of the area under the ROC curve for multiple class classification problems, Machine learning 45, vol.2, pp.171-186, 2001.

J. A. Hardy and G. A. Higgins, Alzheimer's disease : the amyloid cascade hypothesis, Science 256, vol.5054, pp.184-185, 1992.

J. Hardy and D. Allsop, « Amyloid deposition as the central event in the aetiology of Alzheimer's disease, Trends in Pharmacological Sciences, vol.12, pp.383-388, 1991.

J. Hardy and D. J. Selkoe, « The Amyloid Hypothesis of Alzheimer's Disease : Progress and Problems on the Road to Therapeutics ». en, Science 297, vol.5580, pp.353-356, 2002.

S. Harirforoosh, W. Asghar, and F. Jamali, « Adverse effects of nonsteroidal antiinflammatory drugs : an update of gastrointestinal, cardiovascular and renal complications ». eng, Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, vol.16, pp.821-847, 2013.

S. A. Harris and E. A. Harris, « Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease ». eng, Frontiers in Aging Neuroscience, vol.10, p.48, 2018.

A. E. Hoerl and R. W. Kennard, « Ridge Regression : Biased Estimation for Nonorthogonal Problems, Technometrics 12.1, pp.55-67, 1970.

C. Holmes, « Review : systemic inflammation and Alzheimer's disease ». eng, Neuropathology and Applied Neurobiology, vol.39, pp.51-68, 2013.

G. Hughes, « On the mean accuracy of statistical pattern recognizers, IEEE Transactions on Information Theory, vol.14, pp.55-63, 1968.

A. Hyvarinen, « Fast and robust fixed-point algorithms for independent component analysis, IEEE transactions on Neural Networks, vol.10, pp.626-634, 1999.

S. Iddi, « Predicting the course of Alzheimer's progression ». en, Brain Informatics 6.1, p.6, 2019.

P. S. Insel, « Assessing risk for preclinical ?-amyloid pathology with APOE, cognitive, and demographic information, Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, vol.4, pp.76-84, 2016.

C. R. Jack and D. A. Bennett, « NIA-AA Research Framework : Toward a biological definition of Alzheimer's disease ». en. In : Alzheimer's & Dementia 14, vol.4, pp.535-562, 2018.

C. R. Jack and D. S. Knopman, « Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, Lancet neurology 9, pp.70299-70305, 2010.

C. R. Jack and H. J. Wiste, « Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings ». en, Brain 138, vol.12, pp.3747-3759, 2015.

D. Jaturapatporn, « Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease ». eng, The Cochrane Database of Systematic Reviews, vol.2, p.6378, 2012.

P. Johnson, « Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease, BMC Bioinformatics, vol.15, 2014.

. Junwei-ding and . Huang, « Prediction of MCI to AD conversion using Laplace Eigenmaps learned from FDG and MRI images of AD patients and healthy controls ». en, 2017 2nd International Conference on Image, Vision and Computing (ICIVC), pp.660-664, 2017.

E. Karran, M. Mercken, and B. D. Strooper, « The amyloid cascade hypothesis for Alzheimer's disease : an appraisal for the development of therapeutics ». en, Nature Reviews Drug Discovery, vol.10, pp.698-712, 2011.

M. Kate and . Ten, « MRI predictors of amyloid pathology : results from the EMIF-AD Multimodal Biomarker Discovery study, Alzheimer's Research & Therapy 10, vol.1, p.100, 2018.

K. Kauppi, « Combining polygenic hazard score with volumetric MRI and cognitive measures improves prediction of progression from mild cognitive impairment to Alzheimer's disease, Frontiers in Neuroscience, vol.12, 2018.

J. Kim and B. Lee, « Identification of Alzheimer's disease and mild cognitive impairment using multimodal sparse hierarchical extreme learning machine ». en, Human Brain Mapping, 2018.

E. King, « Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias ». eng, Neurosurgery, and Psychiatry 89, vol.4, pp.339-345, 2018.

T. Kishi, « Memantine for Alzheimer's Disease : An Updated Systematic Review and Meta-analysis ». eng, Journal of Alzheimer's disease : JAD 60, vol.2, pp.401-425, 2017.

I. O. Korolev, « Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification ». en, PLOS ONE, vol.11, issue.2, 2016.

I. Koval, S. Allassonnière, and S. Durrleman, « Simulation of virtual cohorts increases predictive accuracy of cognitive decline in MCI subjects, 2019.

I. Koval and A. Bône, « Simulating Alzheimer's disease progression with personalised digital brain models, 2018.

F. Q. Lauzon, « An introduction to deep learning ». en, 2012 11th International Conference on Information Science, Signal Processing and their Applications (ISSPA), pp.1438-1439, 2012.

S. Leandrou, « Quantitative MRI Brain Studies in Mild Cognitive Impairment and Alzheimer's Disease : A Methodological Review, IEEE Reviews in Biomedical Engineering, vol.11, pp.97-111, 2018.

B. Lei, « Discriminative learning for Alzheimer's disease diagnosis via canonical correlation analysis and multimodal fusion, Frontiers in Aging Neuroscience 8.MAY, 2016.

L. I. Deng, « The MNIST Database of Handwritten Digit Images for Machine Learning Research, IEEE Signal Processing Magazine, vol.29, pp.141-142, 2012.

Y. Li, « Indirect relation based individual metabolic network for identification of mild cognitive impairment, Journal of Neuroscience Methods, vol.309, pp.188-198, 2018.

W. Lin, « Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection ». eng, JAMA neurology, 2019.

W. Lin, « Convolutional neural networks-based MRI image analysis for the Alzheimer's disease prediction from mild cognitive impairment, Frontiers in Neuroscience, vol.12, 2018.

C. L. Lopez, « The Alzheimer's Prevention Initiative Generation Program : Evaluating CNP520 Efficacy in the Prevention of Alzheimer's Disease. » In : The journal of prevention of Alzheimer, pp.242-246, 2017.

A. Marengoni, « Patterns of Chronic Multimorbidity in the Elderly Population ». en, Journal of the American Geriatrics Society, vol.57, pp.225-230, 2009.

R. V. Marinescu, « TADPOLE Challenge : Prediction of Longitudinal Evolution in Alzheimer's Disease, 2018.

C. Martin, « Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation ». eng, Journal of Alzheimer's disease : JAD 39, vol.4, pp.849-859, 2014.

M. Massot-mesquida, « Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients, BMC Geriatrics, vol.19, p.7, 2019.

A. Mendes, « Multimorbidity Is Associated with Preclinical Alzheimer's Disease Neuroimaging Biomarkers, Dementia and Geriatric Cognitive Disorders, vol.45, pp.272-281, 2018.

M. M. Mielke, « Indicators of amyloid burden in a population-based study of cognitively normal elderly, Neurology 79, vol.15, pp.1570-1577, 2012.

S. Minhas, « Predicting progression from mild cognitive impairment to Alzheimer's disease using autoregressive modelling of longitudinal and multimodal biomarkers, IEEE Journal of Biomedical and Health Informatics, vol.22, pp.818-825, 2018.

S. Minsker, Y. Zhao, and G. Cheng, « Active Clinical Trials for Personalized Medicine ». en, Journal of the American Statistical Association, vol.111, pp.875-887, 2016.

E. Moradi, « Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects, NeuroImage 104.Supplement C, pp.398-412, 2015.

A. Mubeen, « A six-month longitudinal evaluation significantly improves accuracy of predicting incipient Alzheimer's disease in mild cognitive impairment, Journal of Neuroradiology, vol.44, pp.381-387, 2017.

K. R. Muller, « An introduction to kernel-based learning algorithms, IEEE Transactions on Neural Networks, vol.12, pp.181-201, 2001.

A. Nakamura, « High performance plasma amyloid-? biomarkers for Alzheimer's disease ». en. In : Nature 554, vol.7691, pp.249-254, 2018.

K. Nho, « Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance Imaging, Annual Symposium proceedings / AMIA Symposium. AMIA Symposium, pp.542-546, 2010.

S. Norton, « Potential for primary prevention of Alzheimer's disease : an analysis of population-based data ». eng, The Lancet. Neurology 13, vol.8, pp.788-794, 2014.

J. T. O'brien and K. Herholz, « Amyloid imaging for dementia in clinical practice, BMC Medicine, vol.13, pp.163-169, 2015.

K. Ota, « Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease, Journal of Neuroscience Methods, vol.256, pp.168-183, 2015.

G. Perera, « Factors associated with response to acetylcholinesterase inhibition in dementia : a cohort study from a secondary mental health care case register in london, PloS One 9, vol.11, 2014.

R. C. Petersen, « Mild cognitive impairment due to Alzheimer disease in the community ». eng, Annals of Neurology, vol.74, pp.199-208, 2013.

M. Prince, D. R. Bryce, and D. C. Ferri, The benefits of early diagnosis and intervention ». en. In : Alzheimer's Disease International, p.72, 2011.

M. Prince and A. Wimo, The Global Impact of Dementia : An analysis of prevalence, incidence, cost and trends ». en. In : Alzheimer's Disease International, « World Alzheimer Report, p.87, 2015.

M. Qian and S. A. Murphy, « Performance guarantees for individualized treatment rules ». en, The Annals of Statistics 39, vol.2, pp.1180-1210, 2011.

P. Raamana, « Thickness network features for prognostic applications in dementia, Neurobiology of Aging, vol.36, 2015.

S. Rathore, « A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages ». en, NeuroImage, vol.155, pp.530-548, 2017.

A. Renom-guiteras, « Potentially inappropriate medication among people with dementia in eight European countries, Age and Ageing, vol.47, pp.68-74, 2018.

A. Retico, « Predictive Models Based on Support Vector Machines : Whole-Brain versus Regional Analysis of Structural MRI in the Alzheimer's Disease, Journal of Neuroimaging, vol.25, pp.552-563, 2015.

K. Richardson, « Anticholinergic drugs and risk of dementia : casecontrol study ». en, BMJ, vol.361, 2018.

M. Sabuncu, « A Bayesian algorithm for image-based time-to-event prediction, Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 8184 LNCS, pp.74-81, 2013.

S. Salloway, « Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease, New England Journal of Medicine, vol.370, pp.322-333, 2014.

J. Samper-gonzalez, « Reproducible evaluation of methods for predicting progression to Alzheimer's disease from clinical and neuroimaging data ». en, Medical Imaging 2019 : Image Processing, p.30, 2019.

J. Samper-gonzález, « Reproducible evaluation of classification methods in Alzheimer's disease : framework and application to MRI and PET data ». en, NeuroImage, vol.183, pp.504-521, 2018.

A. Sarica, A. Cerasa, and A. Quattrone, « Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer's Disease : A Systematic Review, Frontiers in Aging Neuroscience 9, p.329, 2017.

A. Satlin, « Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease ». en, Alzheimer's & Dementia : Translational Research & Clinical Interventions 2.1, pp.1-12, 2016.

C. Schuster, « Presymptomatic and longitudinal neuroimaging in neurodegeneration-from snapshots to motion picture : a systematic review ». en, Neurosurgery & Psychiatry, vol.86, pp.1089-1096, 2015.

J. Shaffer, « Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers, Radiology 266, vol.2, pp.583-591, 2013.

L. M. Shaw, « Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects, Annals of neurology 65, vol.4, pp.403-413, 2009.

B. Si, I. Yakushev, and J. Li, « A sequential tree-based classifier for personalized biomarker testing of Alzheimer's disease risk, IISE Transactions on Healthcare Systems Engineering, pp.248-260, 2017.

R. A. Sperling, « Toward defining the preclinical stages of Alzheimer's disease : Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & dementia : the journal of the Alzheimer's Association, pp.280-292, 2011.

T. Tanpitukpongse, « Predictive utility of marketed volumetric software tools in subjects at risk for Alzheimer disease : Do regions outside the hippocampus matter ?, In : American Journal of Neuroradiology, vol.38, pp.546-552, 2017.

K. Thung, « Conversion and time-to-conversion predictions of mild cognitive impairment using low-rank affinity pursuit denoising and matrix completion, Medical Image Analysis, vol.45, pp.68-82, 2018.

T. Tong, « A novel grading biomarker for the prediction of conversion from mild cognitive impairment to Alzheimer's disease, IEEE Transactions on Biomedical Engineering, vol.64, pp.155-165, 2017.

D. Tosun, S. Joshi, and M. W. Weiner, « Neuroimaging Predictors of Brain Amyloidosis in Mild Cognitive Impairment, Annals of neurology 74, vol.2, pp.188-198, 2013.

N. Tzeng, « Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan ». eng, Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol.15, pp.417-429, 2018.

D. Vecchio, « Sustainable method for Alzheimer dementia prediction in mild cognitive impairment : Electroencephalographic connectivity and graph theory combined with apolipoprotein E », Annals of Neurology, vol.84, pp.302-314, 2018.

L. Vermunt, « Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype, Alzheimer's & Dementia : The Journal of the Alzheimer's Association 15, vol.7, pp.888-898, 2019.

G. Vivar, « Multi-modal Disease Classification in Incomplete Datasets Using Geometric Matrix Completion, 2018.

J. L. Watson, « Obstacles And Opportunities In Alzheimer's Clinical Trial Recruitment, Health affairs, pp.574-579, 2014.

J. Wen, « How serious is data leakage in deep learning studies on Alzheimer's disease classification ? » en, Proceedings of : Human Brain Mapping (HBM), p.8, 2019.

E. Westman and C. Aguilar, « Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment, Brain Topography, vol.26, pp.9-23, 2013.

E. Westman, J. Muehlboeck, and A. Simmons, « Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion, NeuroImage 62.1, pp.229-238, 2012.

, What is Alzheimer's ?, 2019.

R. A. Whitmer, « Midlife cardiovascular risk factors and risk of dementia in late life, Neurology 64, vol.2, pp.277-281, 2005.

M. M. Witte, « Clinical use of amyloid-positron emission tomography neuroimaging : Practical and bioethical considerations, Alzheimer's & Dementia : Diagnosis, vol.1, pp.358-367, 2015.

D. H. Wolpert, R. .-;-de, and . Roy, « The Supervised Learning No-Free-Lunch Theorems ». en. In : Soft Computing and Industry. Sous la dir, pp.25-42, 2002.

D. H. Wolpert and W. G. Macready, « No Free Lunch Theorems for Optimization ». en, IEEE TRANSACTIONS ON EVOLUTIONARY COMPUTA-TION, vol.1, issue.1, p.16, 1997.

S. Wooller, Artificial intelligence can predict Alzheimer's 6 years earlier than medics, study finds. en-US, 2018.

M. A. Wozniak, « Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation ». eng, Neuroscience Letters, vol.429, issue.2-3, pp.95-100, 2007.

D. Ye, K. Pohl, and C. Davatzikos, « Semi-supervised pattern classification : Application to structural MRI of Alzheimer's disease, Proceedings -International Workshop on Pattern Recognition in NeuroImaging, PRNI 2011, pp.1-4, 2011.

Y. Zhao, « Estimating Individualized Treatment Rules Using Outcome Weighted Learning ». en, Journal of the American Statistical Association, vol.107, pp.1106-1118, 2012.